Latest Vertex Pharmaceuticals Incorporated (VRTX) News on September 18, 2025
MT Newswires
6 hours ago
Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy
Simply Wall St.
a day ago
How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025
MT Newswires
7 days ago
Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating
Insider Monkey
15 days ago
Here’s Why Vertex Pharmaceuticals (VRTX) is on Loomis Sayles Growth Fund’s Detractors List
Insider Monkey
16 days ago
Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings
Yahoo Finance
18 days ago
August jobs report due out as Fed uncertainty looms: What to watch this week
MT Newswires
20 days ago
DBS Bank Adjusts Price Target on Vertex Pharmaceuticals to $480 From $600, Maintains Buy Rating
Simply Wall St.
a month ago
Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)
MT Newswires
a month ago
Rothschild & Co Redburn Adjusts PT on Vertex Pharmaceuticals to $530 From $560, Maintains Buy Rating
Insider Monkey
a month ago
Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged
GlobeNewswire
a month ago
Vortex Energy Successfully Deploys ANT Sensors at Robinsons River Salt Project
![[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/cdn/transform/width=500,quality=90,format=webp/https://cdn.finquota.com/news/d618dafd-47e8-4780-8054-ca0b4a5b52d3.png)
StockStory
a month ago
The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
StockStory
a month ago
VRTX Q2 2025 Deep Dive: New Product Launches and Pipeline Update in a Volatile Market
Simply Wall St.
a month ago
Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings May Just Be The Starting Point
Mining Technology
a month ago
Vertex Minerals to commence high-grade ore production at Reward gold mine
Simply Wall St.
a month ago
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 91% Above Its Share Price
Simply Wall St.
a month ago
Safety Insurance Group's (NASDAQ:SAFT) Shareholders Will Receive A Bigger Dividend Than Last Year
Simply Wall St.
a month ago
Canadian Natural Resources Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St.
a month ago
Citizens Financial Services Second Quarter 2025 Earnings: EPS: US$1.76 (vs US$1.10 in 2Q 2024)
Simply Wall St.
a month ago
Earnings Beat: Saputo Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
MT Newswires
a month ago
Vertex Pharmaceuticals Insider Bought Shares Worth $3,895,768, According to a Recent SEC Filing
Simply Wall St.
a month ago
Vertex Pharmaceuticals (VRTX) Reports Strong Q2 2025 Revenue Growth with US$2,965 Million
Insider Monkey
a month ago
Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial
MT Newswires
a month ago
Wells Fargo Upgrades Vertex Pharmaceuticals to Overweight From Equalweight, Price Target is $460
Clinical Trials Arena
a month ago
Vertex’s Journavx successor culled after falling short in Phase II trial
Motley Fool
a month ago
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
Barrons.com
a month ago
These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More
Investor's Business Daily
a month ago
Stock Market Today: Dow Rises Ahead Of Key Data; American Eagle, Coinbase Slide (Live Coverage)
MT Newswires
a month ago
Canaccord Genuity Adjusts Price Target on Vertex Pharmaceuticals to $411 From $424
GlobeNewswire
a month ago
Vortex Energy Mobilizes Field Crews for ANT Survey at Robinsons River Salt Project
MT Newswires
a month ago
HC Wainwright Adjusts Price Target on Vertex Pharmaceuticals to $478 From $550, Maintains Buy Rating
MT Newswires
a month ago
RBC Cuts Price Target on Vertex Pharmaceuticals to $405 From $430, Keeps Sector Perform Rating
